Stopping Alzheimer's disease before symptoms start The Lancet Neurology ++... ++

Stopping Alzheimer's disease before symptoms start The Lancet Neurology https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(26)00045-1/fulltext?dgcid=raven_jbs_etoc_email Mar 2026 Volume 25Number 3p213-324, e3-e9 https://www.thelancet.com/journals/laneur/issue/vol25no3/PIIS1474-4422(26)X2001-4 Safety and efficacy of fordadistrogene movaparvovec in ambulatory participants with Duchenne muscular dystrophy (CIFFREO): a phase 3, double-blind, randomised, placebo-controlled study Prof Francesco Muntoni, MDa,b f.muntoni@ucl.ac.uk ∙ Andres Nascimento, MDc ∙ Jinhong Shin, MDd ∙ Prof Michela Guglieri, MDe ∙ Georg M Stettner, MDf,g ∙ Aravindhan Veerapandiyan, MDh ∙ et al. https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(26)00036-0/abstract?dgcid=raven_jbs_etoc_feature_laneur Safety and efficacy of intensive task-specific training in people with recent spinal cord injury: a phase 3, pragmatic, randomised, assessor-blinded, superiority trial Joanne V Glinsky, PhDa,c ∙ Jackie Chu, MPhila,c ∙ Christine Rimmer, GDipd ∙ Sharon Roberts, BSc [Physio]d ∙ Giorgio Scivoletto, PhDe ∙ Federica Tamburella, PhDe,f ∙ et al. https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(26)00010-4/fulltext?dgcid=raven_jbs_etoc_feature_laneur